[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571703":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":21,"responsibleParty":39,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"ACHD cohort",null,"Adult patients with congenital heart disease either untreated, corrected or palliated, evaluated in our ACHD Outpatient Clinic between 2014 and 2026 with at least one-year follow-up.",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Francesca Graziani, MD, PhD","CONTACT","00390630154432","francesca.graziani@policlinicogemelli.it",{"name":19,"role":15,"phone":16,"phoneExt":10,"email":20},"Giulia Iannaccone, MD","giulia.iannaccone@guest.policlinicogemelli.it",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Fondazione Policlinico Universitario Agostino Gemelli","RECRUITING","Rome","RM","00168","Italy","IT",{"type":31,"coordinates":32},"Point",[33,34],12.51133,41.89193,{"lat":34,"lon":33},[37,38],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"name":19,"role":15,"phone":16,"phoneExt":10,"email":20},{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Graziani Francesca","MD, PhD","100571703","prognosis-in-adult-patients-with-congenital-heart-disease-100571703",false,"NCT06723704","Prognosis in Adult Patients With Congenital Heart Disease","Prognosis in Adult Patients With Congenital Heart Disease: an Observational Study","PRO-ACHD","Inclusion Criteria:\n\n* Patients evaluated in our ACHD Outpatient Clinic between January 2014 and December 2026\n* Age ≥ 18 years\n\nExclusion Criteria:\n\n* Patients without congenital heart disease confirmed during the first evaluation\n* Impossibility to retrieve information about the first clinical evaluation in our clinic from our electonic datasets\n* Follow up shorter than one-year\n* Refused consent to participate to the study.","ALL","18 Years",{"count":54,"type":55},450,"ESTIMATED","OBSERVATIONAL","This is a mono-center observational ambispective study in which adult patients with congenital heart disease evaluated at our institution will be enrolled.\n\nThe primary endopoint is to assess the clinical and echocardiographic predictors of adverse events during follow-up (death, arrhythmias, cardiac hospitalization).\n\nThe secondary endpoints are: 1) evaluation of the incidence of the singular components of the primary endpoint; 2) evaluation of the prognostic impact of acquired lesions, including valve disease not present at birth; 3) need for surgical\u002Fpercutaneous interventions during follow up.\n\nParticipants will be evaluated in the context of scheduled follow-up visits in our Outpatient ACHD Clinic. No interventions\u002Fdrug administration will be performed other than those required by standard clinical practice.",[59],"Adult Congenital Heart Disease",[61,62,63,64,65],"adult congenital heart disease","ACHD","prognosis","long-term","follow-up","2024-12-04",{"date":68,"type":69},"2024-12-09","ACTUAL",{"date":71,"type":69},"2022-03-21",{"date":73,"type":55},"2026-12-31",{"name":5,"class":6},1]